- Market Realist•1 hour ago
Novartis’s (NVS) Innovative Medicines segment contributed ~66.6% to overall 1Q17 revenue, or $7.7 billion.
- Market Realist•3 hours ago
On April 25, 2017, Novartis (NVS) reported a 2.0% rise in revenues at constant currencies for 1Q17. Revenues fell due to a 3.0% negative impact of foreign exchange.
- Market Realist•4 hours ago
Novartis (NVS) released its 1Q17 earnings on April 25, 2017, reporting a 25.0% rise in revenues at constant exchange rates compared to 1Q16.
NVS : Summary for Novartis AG - Yahoo Finance
Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||76.99 - 77.51|
|52 Week Range||66.93 - 83.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||27.52|
|Dividend & Yield||2.72 (3.71%)|
|1y Target Est||N/A|